A commitment to hope: Richard Nixon and the National Cancer Act

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Spotlight article 

On Dec.  23, 1971, in the East Room of the White House, describing it as something akin to  a Christmas gift to the American people,  President Richard Nixon signed the National Cancer Act of 1971.

“We are here today for the purpose of signing the Cancer Act of 1971,” President Nixon said in his remarks before signing the act. “And I hope that in the years ahead, that we may look back on this day and this action as being the most significant action taken during this administration,” he added.

To honor and celebrate the milestone 50th anniversary of the signing of the National Cancer Act, the Richard Nixon Foundation has gathered Nobel Prize laureates and America’s top cancer doctors for the inaugural Nixon National Cancer Conference.

The conference opened at the Richard Nixon Presidential Library and Museum in Yorba Linda, California on Dec. 1, and included an in-depth and fascinating look back at the history of the National Cancer Act as well as the official opening of a new special exhibit at the Nixon Library entitled, “A Commitment to Hope: Richard Nixon and the National Cancer Act.”


Quote of the week

I hope that in the years ahead, that we may look back on this day and this action as being the most significant action taken during this administration.

Richard Nixon

Recent contributions


This column features the latest posts to the Cancer History Project by our growing list of contributors

The Cancer History Project is a free, web-based, collaborative resource intended to mark the 50th anniversary of the National Cancer Act and designed to continue in perpetuity. The objective is to assemble a robust collection of historical documents and make them freely available. 

Access to the Cancer History Project is open to the public at CancerHistoryProject.com. You can also follow us on Twitter at @CancerHistProj.

Is your institution a contributor to the Cancer History Project? Eligible institutions include cancer centers, advocacy groups, professional societies, pharmaceutical companies, and key organizations in oncology. 

To apply to become a contributor, please contact admin@cancerhistoryproject.com.

Table of Contents

YOU MAY BE INTERESTED IN

For nearly 25 years, business executive Lou Weisbach and urologist Richard J. Boxer have argued that finding the money to finance the cures for devastating diseases is not as difficult as it appears. To start finding the cures, the U.S. Department of the Treasury needs to issue some bonds—$750 billion worth. Next, you hire CEOs—one...

There is general agreement that the United States spends too much on health care, especially on pharmaceuticals.  But what we spend on drugs is not simply a function of price. If eggs double in price, people can simply cut the number of eggs they eat in half.  Simply stated, cost is the product of (price per unit times the number of units purchased). 
What did President Richard M. Nixon and Senator Edward M. Kennedy have in common? They each played a pivotal role in the passage of the National Cancer Act signed by Nixon on Dec. 23, 1971. The NCA established the National Cancer Program authorizing the initial investment in the NCI-designated Cancer Centers Program. 
When I first proposed targeting PCNA (proliferating cell nuclear antigen) as a therapeutic approach, the response I got was: “No one will ever make a drug against PCNA. It’s undruggable.” The protein lacks enzymatic activity, has a disordered region, and binds to over 200 other proteins within the cell. From a traditional drug development perspective, these characteristics made PCNA an impossible target.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login